KA LAWELAWE HOʻOKOMO ʻANA I KA COAGULATION DIAGNOSIS
NOI NO NĀ REAGENTS ANALYZER
I loko o nā moʻolelo olakino kuʻuna, ua kapa pinepine ʻia ka wai lemona he "mea hoʻoheheʻe koko maoli." Manaʻo ka poʻe he nui e hiki i ka inu ʻana i ke aniani wai lemona i kēlā me kēia lā ke pale i nā ʻūpā koko a hoʻomaikaʻi i ke kahe koko. Eia nō naʻe, aia kekahi kumu ʻepekema no kēia koi? Hiki i ka wai lemona ke "hoʻoheheʻe" maoli i ke koko?
No ka pane ʻana i kēia nīnau, pono mua mākou e wehewehe i ka wehewehe ʻepekema o "blood thinner."
Ma ke ʻano lapaʻau, ua māhele nui ʻia nā lāʻau hoʻokahe koko i ʻelua mau māhele: nā anticoagulants (e like me warfarin a me heparin), ka mea e kāohi ai i ka hana o nā mea coagulation e pale ai i ke kāpili ʻana o ke koko; a me nā lāʻau antiplatelet (e like me aspirin), ka mea e pale ai i ka thrombosis ma ke kāohi ʻana i ka platelet aggregation. Loaʻa i kēia mau lāʻau nā hopena pharmacological i wehewehe pono ʻia a he mau ala koʻikoʻi ia no ka pale ʻana a me ka mālama ʻana i nā maʻi cardiovascular a me cerebrovascular.
ʻO nā mea nui o ka wai lemona e komo pū me nā antioxidants e like me ka huaora C, ka waikawa citric, a me nā flavonoids. Komo ka huaora C i nā hopena redox i loko o ke kino a he kuleana kona i ka mālama ʻana i ke kūpaʻa o nā paia o nā kīʻaha koko. Ua hōʻike ʻia nā flavonoids he hiki ke anti-inflammatory a me ka hana endothelial. Ua hōʻike ʻia nā haʻawina holoholona e hiki i kekahi mau mea i loko o nā hua citrus ke kāohi iki i ka platelet aggregation, akā ʻoi aku ka ikaika o kēia hopena ma mua o ka lāʻau lapaʻau.
Ua ʻōlelo ʻia ma kahi noiʻi i paʻi ʻia ma ka American Journal of Clinical Nutrition i ka makahiki 2012, ʻo ka ʻai ʻana i nā hua citrus i kēlā me kēia lā e pili ana paha me ka emi ʻana o ka pilikia o ke kāpili ʻana o ke koko, akā ua pili kēia ʻike i nā hoʻomaikaʻi ʻana o ka ʻai ma mua o ka hopena "thinning" o ka wai lemona wale nō. ʻO ka ʻoiaʻiʻo, ua nāwaliwali loa ka hopena o ka meaʻai ma ke kāpili ʻana o ke koko, ʻaʻole lawa ia e hana hou i nā hopena therapeutic o ka lāʻau lapaʻau.
ʻOi aku ka mea nui, ʻo ka hoʻohālikelike ʻana i ka wai lemona me kahi mea hoʻokahe koko e hoʻopilikia paha i ke olakino. No ka poʻe e lawe ana i nā anticoagulants, ʻo ka ʻai ʻana i ka nui o ka wai lemona e hoʻonui i ka pilikia o ke kahe koko ma muli o ka hopena synergistic o ka meaʻai a me ka lāʻau lapaʻau. ʻO ka poʻe olakino e hilinaʻi nei i ka wai lemona e pale i nā ʻōpū koko me ka hoʻowahāwahā ʻana i ka ʻai kaulike a me ka hoʻoikaika kino e hoʻopaneʻe paha i ka mālama ʻana i ke olakino.
Ma ke ʻano he mea inu momona, loaʻa i ka wai lemona kekahi mau pono no ka puʻuwai ke inu ʻia me ke kaulike. Eia nō naʻe, ʻo kona ʻano hana ma o ka hāʻawi ʻana i nā antioxidants a me ka hoʻonui ʻana i ka inu wai, a ʻaʻole pili pono i ka "hoʻomāmā ʻana i ke koko."
I ka pale ʻana a me ka mālama ʻana i nā maʻi e like me ka thrombosis, he mea nui e hahai i nā ʻōlelo aʻoaʻo lapaʻau, hoʻohana pono i nā lāʻau lapaʻau, a mālama i ka ʻai olakino a me ke ʻano o ka nohona—ʻo kēia ke ala ʻepekema e mālama ai i ke olakino o nā kīʻaha koko.
КОНЦЕНТРАЦИЯ СЕРВИС КОАГУЛЯЦИЯ ДИАГНОСТИКА
АНАЛИЗАТОР РЕАГЕНТОВ ПРИМЕНЕНИЕ
Ua komo nui ʻo Beijing Succeeder Technology Inc. (code stock: 688338) i ke kahua o ka ʻike ʻana i ka coagulation mai kona hoʻokumu ʻia ʻana i ka makahiki 2003, a ua kūpaʻa ʻo ia e lilo i alakaʻi ma kēia kahua. Me ke keʻena nui ma Beijing, he hui R&D, hana a kūʻai aku ikaika ka hui, e kālele ana i ka hana hou a me ka hoʻohana ʻana i ka ʻenehana ʻike thrombosis a me hemostasis.
Me kona ikaika loea koʻikoʻi, ua lanakila ʻo Succeeder i 45 mau palapala sila i ʻae ʻia, me 14 mau palapala sila i hana ʻia, 16 mau palapala sila hoʻohālike pono a me 15 mau palapala sila hoʻolālā. Loaʻa i ka hui he 32 mau palapala hoʻopaʻa inoa huahana lāʻau lapaʻau Papa II, 3 mau palapala hoʻopaʻa inoa Papa I, a me ka palapala hōʻoia EU CE no 14 mau huahana, a ua hala i ka palapala hōʻoia ʻōnaehana hoʻokele maikaʻi ISO 13485 e hōʻoia i ka maikaʻi a me ke kūpaʻa o ka maikaʻi o ka huahana.
ʻAʻole wale ʻo Succeeder kahi ʻoihana koʻikoʻi o ka Beijing Biomedicine Industry Leapfrog Development Project (G20), akā ua pae maikaʻi ʻo ia ma ka Science and Technology Innovation Board i ka makahiki 2020, e hoʻokō ana i ka hoʻomohala leapfrog o ka ʻoihana. I kēia manawa, ua kūkulu ka ʻoihana i kahi pūnaewele kūʻai aku ma ka ʻāina holoʻokoʻa e uhi ana i nā haneli o nā ʻelele a me nā keʻena. Kūʻai maikaʻi ʻia kāna huahana ma ka hapa nui o ka ʻāina. Ke hoʻonui nei hoʻi i nā mākeke ma waho a ke hoʻomaikaʻi mau nei i kona hoʻokūkū honua.
Kāleka ʻoihana
WeChat Kina